Clayton Pickering
Family Medicine · Whitney, TXNPI 1689667826
Payments from drug & device makers
Across 657 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$2K
- AbbVie$1K
- AstraZeneca$1K
- Novo Nordisk$1K
- Teva Pharmaceuticals USA, Inc.$517
- GSK$515
- plus $6K from 40 others
What the payments were for
- Consulting fees$1,20010%
- Travel & lodging$3042%
- Food & beverage$10,76987%
- Education$1371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,411 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 215 | $252,624 |
| EliquisApixaban | 311 | $129,906 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 163 | $111,825 |
| OzempicSemaglutide | 87 | $109,218 |
| FarxigaDapagliflozin Propanediol | 165 | $79,206 |
| TrulicityDulaglutide | 79 | $78,420 |
| LinzessLinaclotide | 112 | $58,062 |
| JardianceEmpagliflozin | 86 | $55,546 |
| MyrbetriqMirabegron | 126 | $52,457 |
| NuedextaDextromethorphan Hbr/Quinidine | 62 | $47,273 |
| JanuviaSitagliptin Phosphate | 127 | $40,846 |
| RexultiBrexpiprazole | 22 | $34,712 |
| NuplazidPimavanserin Tartrate | 14 | $34,423 |
| RybelsusSemaglutide | 18 | $32,755 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $28,130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $447 | $331,044294 claims |
| PfizerEliquis, Nurtec Odt, Premarin | $458 | $160,553339 claims |
| Novo NordiskOzempic, Rybelsus | $1,123 | $141,973105 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $515 | $138,138224 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,128 | $107,336193 claims |
| MerckJanuvia, Lagevrio (Eua), Belsomra | $393 | $73,844175 claims |
| AbbVieLinzess, Creon | $1,304 | $66,495138 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $24 | $63,93898 claims |
| Astellas Pharma US IncMyrbetriq | $260 | $52,457126 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $54 | $47,27362 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $181 | $34,71222 claims |
| Johnson & JohnsonXarelto | $92 | $26,23066 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Whitney
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.